Aclarion Completes First Nociscan Exams in Norway Trial

Aclarion Inc. announced the completion of the first Nociscan exams for patients enrolled in the LIFEHAB Trial in Norway. The randomized controlled trial is studying 202 patients with low back pain lasting more than one year and will compare outcomes between lumbar interbody fusion surgery and multidisciplinary rehabilitation. Nociscan was selected for use in the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here